One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...

The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 to $346.

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...

Pfizer PFE will report its second-quarter 2025 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales ...

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

The reduced rate will still be almost 10 times the average monthly out-of-pocket costs paid by commercially insured patients.

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and nationwide delivery.

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Bristol-Myers Squibb and Pfizer announce a 43% discount on Eliquis for uninsured U.S. patients, challenging traditional drug pricing models. Image (c) ConsumerAffairs ...

The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate. Three-person IVF technique is aiding UK children's health. Johnson & Johnson's ...

BMS and Pfizer have established a direct-to-patient online program, Eliquis 360 Support, which offers the blood thinner at a discount price.